Business

Global Medical Marijuana Market Analysis, Trends, Growth, Research And Forecast 2035

Mr Accuracyreports has published a new research report titled “

Global Medical Marijuana Market Size By Species (Cannabis Indica, Sativa), By Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)), By End-Use (Pharmaceutical Industry, Research And Development Centres), By Method of Administration (Smoking, Vaporizers), By Geographic Scope And Forecast

” in its research database. Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology, and Graphs –

https://www.mraccuracyreports.com/request/download/5/853362/Medical-Marijuana-Market

The primary purpose of this market research is to understand customer needs, preferences, and behaviors. By analyzing this data, businesses can develop effective marketing strategies, improve products or services, and enhance customer satisfaction. Additionally, current market research 2024 helps identify market trends, assess the competitive landscape, and evaluate the potential for new products or servicesBrowse Complete Report Here-

https://www.mraccuracyreports.com/marketreports/5/853362/Medical-Marijuana-Market

Medical Marijuana Market Size And Forecast

Medical Marijuana Market size was valued at USD 10.67 Billion in 2021 and is projected to reach USD 60.19 Billion by 2030, growing at a CAGR of 21.22% from 2023 to 2030.

The rising awareness among patients and healthcare professionals regarding the benefits and applications of medical marijuana has obliged the regulatory authorities to consider and legalize medical marijuana. More than 30 countries have legalized marijuana’s medical uses through various national programs. The Global Medical Marijuana Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Medical Marijuana Market Definition

Medical marijuana is generally known as medical cannabis. It is a particular type of marijuana plant and its products possess treatments that have been used to treat several conditions and diseases, mostly chronic pain and nausea. Medical marijuana is used for a variety of health disorders, including pain management and epilepsy, amongst others. Several efforts are being made in Central Asia & the Middle East to legalize and regulate the use of medical marijuana in several regions. Medicinal marijuana is an herbal supplement medication obtained from marijuana plants that are used to treat some particular symptom or ailment.

While the scientific term of marijuana ‘cannabis’ refers to the plant genus. Marijuana is also used while referring to the crude narcotic extracted from the plant’s leaves and flowers. Various pharmaceutical medications based on marijuana have developed and been made accessible for medical use in a purified and standardized configuration. Patients should have a diagnosed sickness that is on their state’s permitted illness lists, Patients should also have and prescription from their doctor, to be able to procure medical marijuana for medicinal or therapeutic purposes.

After this process, the patient can submit an application for a medical marijuana card, which will allow him/her to shop at pharmacies for medical marijuana and related items. The THC (Tetra hydro cannabinol) present in marijuana is used to treat nausea in treatments such as chemotherapy and other treatments. but, the United States boards and FDA (Food and drug administration) authorities are yet to approve cannabis as a legal medicine. Marijuana also has cannabinol which is used for pain management treatments, blood pressure, seizures, concentration, appetite, muscular problems, memory, Sensory stimulus, and other therapies.

Global Medical Marijuana Market Overview

Cannabis is very safe and has very few side effects when compared to other treatment choices. Medical marijuana has also found its usage along with other treatments to enhance its efficacy or combat adverse side effects. For example, Medical Marijuana is highly effective in reducing nausea and increasing appetite among chemotherapy patients. Likely, medical marijuana is also used as a blend with traditional opioid painkillers, which helps patients in reducing the dosage and frequency of opioids considerably and provides better pain relief. Due to the increasing popularity of medical marijuana more and more investment is being made in the research and development segment for finding more and more uses for medical marijuana and more reasons to legalize it in more and more regions of the world.

The gradually aging population around the world has played an important role in driving the demand for medical cannabis as geriatric patients are more prone to chronic diseases and require more physician visits. There are a few difficulties in medical marijuana for business making. While multiple national regulatory bodies have legalized the controlled use of recreational and medical marijuana in their respective countries. Several countries have deserted their legal use because of the concern regarding the high abuse of marijuana among the young generation which is high even when the substance is prohibited and what will it result when marijuana is legalized which turns out as a restraint for the Medical Marijuana Market. Regulatory authorities are required to maintain control over the usage of medical marijuana for medical and clinical purposes. Therefore, a lot of authorized workforces are required to handle this.

The lack of such a skilled workforce hampers this market growth. The industry has also witnessed a downfall due to the ease of availability of recreational marijuana. This may restrain the growth of the Medical Marijuana Market. The recent COVID-19 pandemic has resulted in increased usage of medical marijuana among several states in the U.S. and Canada. There was a major upsurge in the number of medical marijuana patients and supply of medical marijuana across the U.S. and Europe while the COVID-19 pandemic. Now with the approval of medical marijuana for recreational application or adult use of cannabis in major U.S. states such as California, Colorado, and Washington among others.

Global Medical Marijuana Market: Segmentation Analysis

The Global Medical Marijuana Market is segmented on the basis of Species, Derivatives, End-Use, Method of Administration, and Geography.

Medical Marijuana Market, By Species

  • Cannabis Indica
  • Sativa
  • Hybrid

Based on Species, the market is segmented into Cannabis Indica, Sativa, and Hybrid. At present, Cannabis Indica is leading the market accounting for the largest share. It is majorly used to treat insomnia, relax the muscles, relieving body pains, headaches, and migraines. Cannabis Indica plants are short, wide-leaved, bushy plants. These plants grow quickly and higher yield than the Sativa variety. Medicine that is produced from cannabis Indica plants can be lower in THC and higher in CBD than the Sativa strain.

Medical Marijuana Market, By Derivatives

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)
  • Others

Based on Derivatives, the market is segmented into Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others. cannabidiol (CBD) is highly used for medical purposes because of its non-psychotic advantage and low toxicity levels, while THC is used to diminish the side effects of AIDS and cancer treatment.

Medical Marijuana Market, By End-Use

  • Pharmaceutical Industry
  • Research and Development Centres
  • Others

Based on End-Use, the market is bifurcated into the Pharmaceutical Industry, Research and Development Centers, and Others. At present, the pharmaceutical industry is the biggest user of medical marijuana. Research and Development are also predicted to grow as more and more investment is being made in the R&D of marijuana.

Medical Marijuana MarketBy Method of Administration

  • Oral Solutions and Capsules
  • Smoking
  • Vaporizers
  • Topicals
  • Others

Based on Method of Administration, the market is segmented into Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others. Oral solutions and capsules are the biggest segment and account for the largest market share. Oral solutions and capsules hold the biggest share because of their ease to use and can be added to food preparations without any harm and provide the same result.

Medical Marijuana MarketBy Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

On the basis of Geography, the Global Medical Marijuana Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region possesses the leading position in the Medical Marijuana Market. North American region leads the market because it was the first region to legalize the use of marijuana for both recreational and medical uses, this has been a major driver for the growth of the Medical Marijuana Market in this region. The rest of the key regions for the Medical Marijuana Market are Europe, Asia Pacific, Latin America, and Middle East, and Africa.

Key Players

The “Global Medical Marijuana Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as GW Pharmaceuticals PLC, MedReleaf Corporation, Canopy Growth Corporation, Aphria Incorporation, Aurora Cannabis Inc, Medical Marijuana, Inc., Green Relief Inc., Cannabis Sativa, INC., Insys Therapeutics, Inc., BOL Pharma, Tilray, Aphria, Inc., MGC Pharmaceuticals Limited, The Peace Naturals Project.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • W Pharmaceutical announced On June 23, 2020, that the UK home office has the reclassified EPIDYOLEX as a schedule 5 drug. This decision intended to move EPIDYOLEX to a low level of control which was required for a patient’s safety.
  • Aurora Cannabis publicized their successful acquisition of Hempco Food and Fiber Inc. In August 2019. Hempco Food and Fiber Inc. is a company associated with providing low-cost hemp raw materials for extraction. This acquisition allows Aurora Cannabis to expand its presence in the U.S. hemp food and hemp-derived CBD markets.
  • Aphria announced its successful acquisition of CC Pharma In January 2019. CC Pharma is a leading German company associated with the distribution of multiple pharmaceutical products including medical marijuana in Germany and across the European region. The vast distribution capabilities of CC Pharma will incline Aphria’s revenue generation and toughen its market presence.

Report Scope

REPORT ATTRIBUTES DETAILS
STUDY PERIOD

2018-2030

BASE YEAR

2021

FORECAST PERIOD

2023-2030

HISTORICAL PERIOD

2018-2020

UNIT

Value (USD Billion)

KEY COMPANIES PROFILED

GW Pharmaceuticals PLC, MedReleaf Corporation, Canopy Growth Corporation, Aphria Incorporation, Aurora Cannabis Inc, Medical Marijuana, Inc.

SEGMENTS COVERED

By Species, By Derivatives, By End-Use, By Method of Administration, and By Geography.

CUSTOMIZATION SCOPE

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports:

Research Methodology of Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Medical Marijuana Market was valued at USD 10.67 Billion in 2021 and is projected to reach USD 60.19 Billion by 2030, growing at a CAGR of 21.22% from 2023 to 2030.
The rising awareness among patients and healthcare professionals regarding the benefits and applications of medical marijuana has obliged the regulatory authorities to consider and legalize medical marijuana.
The major players are GW Pharmaceuticals PLC, MedReleaf Corporation, Canopy Growth Corporation, Aphria Incorporation, Aurora Cannabis Inc, Medical Marijuana, Inc.
The Global Medical Marijuana Market is Segmented on the basis of Species, Derivatives, End-Use, Method of Administration, and Geography.
The sample report for the Medical Marijuana Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.